Category Archives: Healthcare

Analysts Are Bullish on These Healthcare Stocks: Urogen Pharma (URGN), Marinus (MRNS)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Urogen Pharma (URGN – Research Report), Marinus (MRNS – Research Report) and Ligand Pharma (LGND – Research Report) with bullish sentiments. Urogen

Clovis Oncology (CLVS) Receives a Rating Update from a Top Analyst

H.C. Wainwright analyst Edward White maintained a Buy rating on Clovis Oncology (CLVS – Research Report) today and set a price target of $15.00. The company’s shares closed last Wednesday at $5.62. According to TipRanks.com, White is a top 100

Acutus Medical (AFIB) Receives a Hold from Canaccord Genuity

Canaccord Genuity analyst William Plovanic maintained a Hold rating on Acutus Medical (AFIB – Research Report) yesterday and set a price target of $30.00. The company’s shares closed last Wednesday at $28.51. According to TipRanks.com, Plovanic is a 4-star analyst

Canaccord Genuity Keeps a Buy Rating on Vapotherm (VAPO)

In a report released yesterday, William Plovanic from Canaccord Genuity maintained a Buy rating on Vapotherm (VAPO – Research Report), with a price target of $40.00. The company’s shares closed last Wednesday at $32.72. According to TipRanks.com, Plovanic is a

Adamas Pharmaceuticals (ADMS) Receives a Hold from Needham

In a report released today, Serge Belanger from Needham maintained a Hold rating on Adamas Pharmaceuticals (ADMS – Research Report). The company’s shares closed last Wednesday at $4.46. According to TipRanks.com, Belanger is a 4-star analyst with an average return

Analysts Offer Insights on Healthcare Companies: Stoke Therapeutics (NASDAQ: STOK) and Enanta Pharmaceuticals (NASDAQ: ENTA)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Stoke Therapeutics (STOK – Research Report) and Enanta Pharmaceuticals (ENTA – Research Report). Stoke Therapeutics (STOK) Needham analyst Joseph Stringer assigned a Buy rating to